Clinical trial
ACURATE IDE: Transcatheter Replacement of Stenotic Aortic Valve Through Implantation of ACURATE in Subjects InDicatEd for TAVR
NCT03735667 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ACURATE IDE: Transcatheter Replacement of Stenotic Aortic Valve Through Implantation of ACURATE in Subjects InDicatEd for TAVR
- Lead sponsor
- Boston Scientific Corporation
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- June 10, 2019
- Completion date
- September 30, 2029
- Enrollment
- 1,948 (actual)
- Sites
- 75
Conditions
As the registry lists them; a condition with its own page is linked.
aortic stenosis